Keveyis

उत्पाद अवलोकन

About Keveyis

Keveyis is a medication containing the active ingredient Dichlorphenamide, classified as Carbonic Anhydrase Inhibitor. Diclofenamide is a sulfonamide and a carbonic anhydrase inhibitor of the meta-disulfamoylbenzene class. Dichlorphenamide as a carbonic anhydrase inhibitor is used for the treatment of acute angle closure glaucoma.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Dichlorphenamide tablets are indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Dichlorphenamide, the active ingredient in Keveyis, belongs to the Carbonic Anhydrase Inhibitor class. 1 INDICATIONS AND USAGE Dichlorphenamide tablets are indicated for the treatment of primary hyperkalemic periodic paralysis, primary hypokalemic periodic paralysis, and related variants. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Keveyis. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Keveyis for extended periods without medical advice.